about
Current Status and Perspective of Immunotherapy in Gastrointestinal CancersExacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab.Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities.Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma - A case report.Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.Limbic encephalitis following immunotherapy against metastatic malignant melanoma.A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non-small cell lung cancer.
P2860
Q28076970-06DE978D-0292-4478-B38D-597D31CD6A61Q38804604-0D4B910C-3A24-4229-B657-431D748401F3Q39430042-37B26A11-E1F0-4FEC-B238-A4E2114BEEFEQ42329560-EBEC1A5B-D733-4A26-B6A6-25F9C94D5FD6Q47134535-1ED7826E-0B13-4D9A-A925-E108EB010423Q48809378-71518A6C-0054-4C72-A4DE-ECAE5B52D93CQ51417665-8169DA4F-4F71-4030-8E95-37DA23F72350Q51627654-A6FDB032-448D-464F-ACC8-5EFA563A81B8
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety of pembrolizumab for the treatment of melanoma.
@en
type
label
Safety of pembrolizumab for the treatment of melanoma.
@en
prefLabel
Safety of pembrolizumab for the treatment of melanoma.
@en
P2093
P2860
P1476
Safety of pembrolizumab for the treatment of melanoma.
@en
P2093
James Larkin
Juan Martin-Liberal
Tiana Kordbacheh
P2860
P304
P356
10.1517/14740338.2015.1021774
P407
P577
2015-04-30T00:00:00Z